Last reviewed · How we verify
Propolis 20% — Competitive Intelligence Brief
marketed
Natural product/botanical extract
Dermatology, Wound Care, Oral Health
Small molecule
Live · refreshed every 30 min
Target snapshot
Propolis 20% (Propolis 20%) — Dow University of Health Sciences. Propolis 20% is a natural bee product that exerts antimicrobial, anti-inflammatory, and antioxidant effects through its polyphenolic and flavonoid constituents.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Propolis 20% TARGET | Propolis 20% | Dow University of Health Sciences | marketed | Natural product/botanical extract |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Natural product/botanical extract class)
- Dow University of Health Sciences · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Propolis 20% CI watch — RSS
- Propolis 20% CI watch — Atom
- Propolis 20% CI watch — JSON
- Propolis 20% alone — RSS
- Whole Natural product/botanical extract class — RSS
Cite this brief
Drug Landscape (2026). Propolis 20% — Competitive Intelligence Brief. https://druglandscape.com/ci/propolis-20. Accessed 2026-05-13.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab